Consumer
HIMSS23
Lawrence Whittle, CCO at Verana Health, describes how patient data can be used to improve healthcare, including making clinical trials more efficient and helping clinicians discover which treatments yield the most value.
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the market for digital therapeutics after Pear Therapeutics declared bankruptcy.
The company's ANNE One platform allows for wireless monitoring of neonates and infants' skin and body temperature, heart and respiratory rates, and more.
Oura said the deal could provide new opportunities in payments and data security.
The feature monitors heart rhythms suggestive of atrial fibrillation through the Galaxy Watch.
Patients in Emory's behavioral health program will utilize NeuroFlow's platform to have access to psychotherapy content between scheduled visits.
HIMSS23
Anna Schoenbaum, VP of information services at Penn Medicine, discusses the significance of technology for addressing social determinants of health, as well as how regulations mandate the use and collection of SDOH data.
This is the second round of layoffs in less than a year.
In a blog post, the virtual care provider blasts the insurer for paying it less than other providers in California and refusing to process 'every single' out-of-network claim.
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.